Lab-Grown Human Spinal Cord Model Shows Promise for Injury Repair with ‘Dancing Molecules’
Scientists at Northwestern University have achieved a significant breakthrough in spinal cord injury research by creating the most sophisticated laboratory model to date for studying these complex injuries. This new model utilizes human spinal cord organoids – miniature, lab-grown tissues derived from stem cells – to replicate the biological consequences of trauma and test potential regenerative therapies.
A New Model for Spinal Cord Injury
For the first time, researchers have demonstrated that these human spinal cord organoids accurately reproduce key characteristics of spinal cord injury, including cell death, inflammation and the formation of glial scars. Glial scars are a dense buildup of scar tissue that act as a physical and chemical barrier, hindering nerve repair.
“Dancing Molecules” Show Promise
When these injured organoids were treated with a therapy known as “dancing molecules” – a treatment previously shown to restore movement in animal studies – the results were substantial. The injured tissue exhibited significant neurite outgrowth, indicating that the long extensions of neurons, crucial for communication, began to regrow. The formation of scar-like tissue was markedly reduced.
The “dancing molecules” therapy, which has recently received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA), utilizes controlled molecular motion to repair tissue and potentially reverse paralysis. It works by forming a nanofiber web resembling the spinal cord’s natural structure, with the speed of molecular movement influencing its effectiveness.
How the Model Was Created
The research team, led by Northwestern’s Samuel I. Stupp, guided stem cells over several months to form complex spinal cord tissue containing neurons and astrocytes. Notably, they were the first to incorporate microglia – immune cells of the central nervous system – into the organoids, allowing for a more accurate replication of the inflammatory response following spinal cord injury.
To simulate spinal cord trauma, researchers employed two methods: laceration, mimicking a direct cut, and contusion, replicating blunt force trauma. Both injury types resulted in cell death and glial scar formation, mirroring what occurs in real-world spinal cord injuries.
Looking Ahead
The team plans to further refine their organoid models, developing versions that replicate chronic, long-standing injuries, which are characterized by thicker and more persistent scar tissue. With continued development, these miniature spinal cords could potentially contribute to personalized medicine by enabling the generation of implantable tissue from a patient’s own stem cells, minimizing the risk of immune rejection.
Frequently Asked Questions
What are spinal cord organoids?
Spinal cord organoids are miniature, lab-grown tissues derived from stem cells that closely resemble the structure, cellular diversity, and function of real spinal cord tissue.
What is the “dancing molecules” therapy?
“Dancing molecules” is a therapy that uses controlled molecular motion to repair tissue and potentially reverse paralysis after traumatic spinal cord injury. It’s delivered as a liquid injection that forms a nanofiber web.
What types of spinal cord injuries were simulated in the study?
Researchers simulated two types of spinal cord injuries: laceration, which mimics a direct cut, and contusion, which replicates trauma from a car crash or fall.
Could this research ultimately lead to new treatments for individuals living with paralysis?